Watson Pharmaceuticals Invests in $15M New Jersey Expansion
05/27/2010
"Over the past year, we have outgrown our current administrative headquarters site, as our U.S. and global business has rapidly grown," said Paul Biscaro, Watson president and CEO. "This new facility will ensure that we have a single location for the leadership and shared services functions that are driving our global growth."
New Jersey's Business Employment Incentive Program (BEIP) has extended Watson a grant of approximately $7.3 million over the next 10 years from the state's Economic Development Authority. It has also been approved for a $290,000 Business Retention and Relocation Assistance Grant (BRRAG) to retain 200 jobs in New Jersey.
Watson was the country's third largest producer of generic drugs in 2009 based on prescriptions dispensed. It specializes in drugs for urology and women's health.
Project Announcements
OgMentum ARK Plans Bowling Green, Kentucky, Headquarters-R&D Operations
09/13/2025
Damotech Expand Moberly, Missouri, Operations
09/11/2025
Canada-Based Endurance Technologies Plans Las Cruces, New Mexico, Manufacturing Operations
09/11/2025
Nathan Trotter Plans Henry County, Virginia, Metal Processing Operations
09/11/2025
Samuel Son & Co. Expands Baltimore, Maryland, Operations
09/11/2025
American Rheinmetall Plans Auburn Hills, Michigan, Headquarters Operations
09/11/2025
Most Read
-
Tariffs, Talent, and U.S. Expansion
Q3 2025
-
What We’re Getting Wrong About Gen Z’s Future in the Skilled Trades
Q3 2025
-
Data Center Demand Stabilizes Amid Changing Market Forces
Q3 2025
-
Powering the Next Generation of Projects
Q3 2025
-
A New Course for U.S. Shipbuilding
Q3 2025
-
How Consumer Trends Are Reshaping Food Facilities
Q3 2025
-
Optimizing Your Rail-Served Transportation Network: Strategy Before Steel
Q2 2025